Last reviewed · How we verify

Ginkgo Biloba Extract

Beijing HuiLongGuan Hospital · FDA-approved active Small molecule

Ginkgo biloba extract improves blood flow and reduces oxidative stress through antioxidant and antiplatelet mechanisms.

Ginkgo biloba extract improves blood flow and reduces oxidative stress through antioxidant and antiplatelet mechanisms. Used for Age-related cognitive decline and dementia, Peripheral arterial occlusive disease, Tinnitus.

At a glance

Generic nameGinkgo Biloba Extract
Also known asginkgo biloba, EGb, Symfona®, EGb761
SponsorBeijing HuiLongGuan Hospital
Drug classHerbal extract / Phytopharmaceutical
ModalitySmall molecule
Therapeutic areaNeurology / Cardiovascular
PhaseFDA-approved

Mechanism of action

The extract contains flavonoids and terpenoids that act as free radical scavengers, reducing oxidative damage to cells. It also inhibits platelet aggregation and improves microcirculation, enhancing oxygen and nutrient delivery to tissues, particularly in the brain and peripheral vasculature.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: